Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
Translational Research Program (TRP) supports independent investigators pursuing translational blood cancer research to move promising discoveries toward clinical use and address high unmet need.
Specialized Center of Research Program (SCOR) supports interdisciplinary investigator teams pursuing integrated blood cancer research to move laboratory discoveries toward clinical use.
Scholar in Clinical Research: Career Development Program (CDP) 2026–2027 supports clinical investigators’ salaries to advance patient-involved research on blood cancer prevention, diagnosis, or treatment.
Equity in Access Research Grants support researchers studying insurance-related barriers to blood cancer care and actionable solutions to improve equitable access for patients and survivors.
Brown University’s RTFCCR Clinical Research Grants fund innovative, patient-focused Phase I–III cancer clinical trials to advance treatment and quality of life.